Shiyang Kang

发表

Roles of immunohistochemical staining in diagnosing pulmonary squamous cell carcinoma.

W. Liang, N. Chen, Li Zhang, 2015, Asian Pacific journal of cancer prevention : APJCP.

The Difference of Clinical Characteristics Between Patients With Exon 19 Deletion and Those With L858R Mutation in Nonsmall Cell Lung Cancer

Y. Huang, N. Chen, Li Zhang, 2015, Medicine.

Evaluation of the efficacy and safety of anti-PD-1 and anti-PD-L1 antibody in the treatment of non-small cell lung cancer (NSCLC): a meta-analysis.

W. Liang, Jianxing He, Wei Wang, 2015, Journal of thoracic disease.

ABO blood group, Epstein-Barr virus infection and prognosis of patients with non-metastatic nasopharyngeal carcinoma.

W. Liang, W. Fang, Yaxiong Zhang, 2014, Asian Pacific journal of cancer prevention : APJCP.

Advances in detecting N6-methyladenosine modification in circRNAs.

Shegan Gao, Lixia Ma, Shiyang Kang, 2022, Methods.

Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancer

Fenghua Wang, Yu-hong Li, R. Xu, 2022, BMC Cancer.

PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer

Ying Zhang, Xitao He, Liping Yang, 2022, Frontiers in Oncology.

Network meta-analysis on prophylactic regimens against recurrent hepatitis B virus infection after liver transplantation.

W. Liang, W. Fang, Yaxiong Zhang, 2013, Hepatobiliary surgery and nutrition.

Impact of smoking status on EGFR-TKI efficacy for advanced non-small-cell lung cancer in EGFR mutants: a meta-analysis.

W. Liang, Li Zhang, W. Fang, 2015, Clinical lung cancer.

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

W. Liang, Y. Huang, X. Hou, 2014, Oncotarget.

Efficacy of EP Chemotherapy Followed by IP Chemotherapy Combined with Radiotherapy in the Treatment of Extensive-Stage Small-Cell Lung Cancer.

Shiyang Kang, Chao Lai, 2021, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

W. Liang, Li Zhang, W. Fang, 2014, PloS one.

Optimized selection of three major EGFR-TKIs in advanced EGFR-positive non-small cell lung cancer: a network metaanalysis

Y. Huang, X. Hou, Li Zhang, 2016, Oncotarget.

Impact of EGFR mutation status on tumor response and progression free survival after first-line chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis.

W. Liang, Jianxing He, Wei Wang, 2014, Journal of thoracic disease.

Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non-Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials.

Y. Huang, Li Zhang, Hongyun Zhao, 2017, Clinical lung cancer.

Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients

Y. Huang, N. Chen, Li Zhang, 2016, Oncoimmunology.

The Efficacy of Combining Antiangiogenic Agents with Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer Who Failed First-Line Chemotherapy: A Systematic Review and Meta-Analysis

Y. Huang, Li Zhang, W. Fang, 2015, PloS one.

Multi-Targeted Antiangiogenic Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer: Meta-Analyses of 20 Randomized Controlled Trials and Subgroup Analyses

W. Liang, Y. Huang, Li Zhang, 2014, PLoS ONE.

Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation

Y. Huang, N. Chen, Li Zhang, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A novel computational framework for integrating multidimensional data to enhance accuracy in predicting the prognosis of colorectal cancer

Xiufen Zou, Ruifeng Xu, Qihua Zhang, 2022, MedComm – Future Medicine.

Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer

W. Liang, Wei Wang, G. Peng, 2015, Medicine.

The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs

Ge Li, N. Chen, Li Zhang, 2015, Oncotarget.

Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment

W. Liang, Y. Huang, Chong Zhao, 2016, Chinese journal of cancer.

Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting: A Network Meta‐Analysis

Y. Huang, Li Zhang, W. Fang, 2017, Journal of the National Cancer Institute.

Optimal prophylaxis of chemotherapy-induced nausea and vomiting for moderately emetogenic chemotherapy: a meta-analysis.

Y. Huang, X. Hou, Li Zhang, 2018, Future oncology.

Long Noncoding RNA SNHG5 Induces the NF-κB Pathway by Regulating miR-181c-5p/CBX4 Axis to Promote the Progression of Non-Small Cell Lung Cancer.

J. Lai, Kaibin Zhu, Shiyang Kang, 2022, Archivos de bronconeumologia.

The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis

W. Liang, Mengyao Wang, N. Chen, 2015, Medical Oncology.

JTC-801 alleviates mechanical allodynia in paclitaxel-induced neuropathic pain through the PI3K/Akt pathway.

Shaoyong Wu, Jingdun Xie, Dongtai Chen, 2020, European journal of pharmacology.

Effect of Dexmedetomidine-Assisted Intravenous Anesthesia on Gastrointestinal Motility in Colon Cancer Patients After Open Colectomy

R. Xue, Yingjun Zhang, Shiyang Kang, 2022, Frontiers in Surgery.

Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non-Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials.

Li Zhang, Hongyun Zhao, Zhonghan Zhang, 2017, Clinical lung cancer.

Optimized selection of three major EGFR-TKIs in advanced EGFR-positive non-small cell lung cancer: a network metaanalysis

C. Xue, W. Fang, Yun-peng Yang, 2016, Oncotarget.

Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis.

Y. Huang, Li Zhang, W. Fang, 2017, Journal of the National Cancer Institute.